Immunohematology Market Size & Share, By Product (Analyzers, Reagents), Technology (Biochips, Gel Cards, Microplates, PCR, Erythrocyte-Magnetized Technology), End-User (Hospitals, Diagnostic Laboratories, Blood banks) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

Report ID: FBI 5681| Published Date: Jan-2025| Format: PDF, Excel
Jump to Content
Market Outlook

Market Size and Growth Outlook

Immunohematology Market size is expected to see substantial growth, increasing from USD 2.73 billion in 2024 to USD 4.04 billion by 2034, at a CAGR of over 4%. By 2025, the industry revenue is estimated to be USD 2.83 billion.

Base Year Value (2024)
USD 2.73 billion
CAGR (2025-2034)
4%
Forecast Year Value (2034)
USD 4.04 billion
Historical Data Period
2019-2024
Largest Region
North America
Forecast Period
2025-2034

Get more details on this report

Request Free Sample Report
Snapshot

Immunohematology Market Intelligence Snapshot

Regional Market Dynamics

Segment Momentum

Market Expansion Drivers

Leading Market Participants

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

Regional and Segment Outlook

Market Dynamics

Market Growth Drivers and Industry Trends

Growth Drivers & Opportunity: The Immunohematology Market is expected to witness significant growth due to increasing prevalence of blood disorders and rising demand for blood transfusions. Technological advancements in the field of immunohematology are also driving market growth by improving accuracy and efficiency of blood testing procedures. Additionally, growing awareness about blood group typing and cross-matching for safe transfusions is fueling market expansion. Industry Restraints: The Immunohematology Market is faced with challenges such as high costs associated with advanced blood testing equipment and reagents. Limited availability of skilled professionals trained in immunohematology techniques is also hindering market growth. This shortage of trained personnel is leading to delays in blood testing procedures and impacting overall efficiency in blood banking systems.

Explore Growth Opportunities

Request Free Sample Report
Regional Forecast

Regional Demand Dynamics

Immunohematology Market
Largest Region
North America
39% Market Share in 2024
North America: The immunohematology market size in North America, specifically in the U.S. and Canada, is expected to show significant growth over the forecast period. This can be attributed to the growing prevalence of blood disorders, increasing demand for blood transfusions, and advancements in healthcare infrastructure. The presence of key market players and ongoing research and development activities also contribute to the market growth in this region. Asia Pacific: In the Asia Pacific region, countries such as China, Japan, and South Korea are projected to witness a substantial increase in the demand for immunohematology products and services. The rising awareness about the importance of blood typing and cross-matching, along with the expanding healthcare sector, will drive market growth in these countries. Additionally, the increasing geriatric population and government initiatives to improve blood transfusion services will further boost the market in this region. Europe: The immunohematology market in Europe, particularly in the United Kingdom, Germany, and France, is anticipated to experience steady growth due to the presence of well-established healthcare infrastructure and high adoption of advanced blood typing technologies. The increasing number of blood transfusions and the rising prevalence of chronic diseases are also expected to propel market growth in these countries. Furthermore, collaborations between research institutions and key market players will drive innovation and development in the immunohematology sector in Europe.
🔒 Need data on a specific country or region? Individual country/region reports are available at discounted pricing. Inquire Before Buying

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Immunohematology Market: Analyzers: The segment of analyzers in the immunohematology market plays a crucial role in the blood banking process by efficiently analyzing and identifying blood group compatibility. These analyzers are essential in ensuring the safety and efficacy of blood transfusions, making them a vital component in hospitals, diagnostic laboratories, and blood banks. Reagents: Reagents are another important product segment within the immunohematology market. These substances are used in various tests and procedures to detect and identify specific antibodies and antigens present in blood samples. The demand for high-quality reagents is increasing, driven by the growing need for accurate and reliable blood compatibility testing. Biochips: The technology of biochips is revolutionizing the immunohematology market by offering rapid and automated blood group testing. These biochips provide a high level of accuracy and efficiency in identifying blood group antigens and antibodies, making them a preferred choice for hospitals and diagnostic laboratories. Gel Cards: Gel cards are another technology segment in the immunohematology market that is gaining popularity due to their ease of use and quick results. These cards enable simple and efficient blood grouping and antibody screening, making them a convenient option for healthcare professionals working in blood banks and hospitals. Microplates: Microplates are versatile tools used in the immunohematology market for various tests and procedures. They offer high throughput and automation capabilities, making them ideal for large-scale blood compatibility testing in diagnostic laboratories and blood banks. PCR: Polymerase chain reaction (PCR) technology is increasingly being used in immunohematology for its high sensitivity and specificity in detecting blood group antigens and antibodies. PCR technology is especially useful for detecting rare blood group phenotypes and is a valuable tool in blood banking and transfusion medicine. Erythrocyte-Magnetized Technology: The emerging technology of erythrocyte-magnetized technology is poised to revolutionize the immunohematology market by enabling rapid and accurate blood group testing. This technology utilizes magnetic particles to isolate and detect specific blood group antigens, offering a novel approach to blood compatibility testing in hospitals and blood banks. Hospitals: Hospitals are a key end-user segment in the immunohematology market, as they rely heavily on blood compatibility testing for safe and effective transfusions. The demand for advanced immunohematology products and technologies in hospitals is driven by the need to ensure patient safety and improve outcomes in blood transfusion procedures. Diagnostic Laboratories: Diagnostic laboratories play a crucial role in the immunohematology market by providing comprehensive blood group testing services to healthcare facilities. These laboratories require high-quality analyzers, reagents, and technologies to accurately perform blood compatibility testing and support the diagnosis and treatment of various medical conditions. Blood Banks: Blood banks are essential stakeholders in the immunohematology market, responsible for collecting, testing, and storing blood products for transfusion. These facilities rely on advanced immunohematology products and technologies to ensure the safety and compatibility of blood donations, ultimately saving lives and improving patient care.
Segment Sub-Segment Largest Segment Fastest Growing
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Competitive Landscape

Competitive Landscape and Market Positioning

The immunohematology market is characterized by a competitive landscape where various biotechnology and pharmaceutical companies are actively engaged in developing innovative blood transfusion and compatibility testing solutions. The market is driven by increasing demand for safe blood transfusions, rising prevalence of blood-related disorders, and advancements in technology. Key players are focusing on expanding their product portfolios, enhancing their technological capabilities, and pursuing strategic collaborations and mergers to strengthen their market position. The growing emphasis on patient safety and regulatory compliance further intensifies competition as companies strive to meet stringent requirements while delivering high-quality testing products and services. Top Market Players - Grifols - Abbott Laboratories - Roche Diagnostics - Siemens Healthineers - Ortho Clinical Diagnostics - Bio-Rad Laboratories - Beckman Coulter - Immucor - Becton, Dickinson and Company - Thermo Fisher Scientific
Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Immunohematology Market — Custom Segments

Segment Sub-Segment
No segment data available.

Immunohematology Market — Custom TOC

Custom Chapter Chapter Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
FAQ

Frequently Asked Questions

Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL
Healthcare & Medical Devices
Research Team Overview

This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team
10+Industry Verticals
100+Countries Analyzed
5-7Days Standard
Delivery
13.8K+Research Reports
Published
On-DemandCustomized Research
Available
6Months Analyst
Support
PDF + XLSReport Deliverables
Trust & Compliance
D&B D-U-N-S
GDPR & CCPA Compliant
ISO 9001 Certified (ISO 9001:2015)
SSL Encryption
Secure Payments
Confidential Handling
Research Intelligence
Primary Research Network
Secondary Sources
Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts
Research Workflow & Quality Assurance
01
Data Collection
Verified information gathered through primary and secondary research.
02
Data Triangulation
Cross-validation using multiple independent data sources.
03
Forecast Modelling
Market estimates developed using historical trends and analytical models.
04
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
05
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
06
Final Publication
Released after successful completion of the internal review process.
Report Coverage
Market Assessment
  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics
🏢 Competitive Intelligence
  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis
🚀 Future Outlook
  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →